Follow
In silico identification of clinically approved medicines against the main protease of SARS-CoV-2, causative agent of covid-19. (arXiv:2004.12055v1 [q-bio.BM]) http://arxiv.org/abs/2004.12055
In silico identification of clinically approved medicines against the main protease of SARS-CoV-2, causative agent of covid-19. (arXiv:2004.12055v1 [q-bio.BM]) http://arxiv.org/abs/2004.12055